Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
Open Access
- 20 February 2023
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2023, 1-16
Abstract
Necroptosis, a kind of programmed necrotic cell apoptosis, is the gatekeeper for the host to defend against the invasion of pathogens. It helps to regulate different biological processes regarding human cancer. Nevertheless, studies that determine the impact of death on triple-negative breast cancer (TNBC) are scarce. Therefore, this paper has comprehensively examined the expression as well as clinical significance of necroptosis in TNBC. ConsensusClusterPlus was used to establish a stable molecular classification that used the expression regarding the necroptosis-linked genes. The clinical and immune characteristics of different subclasses were evaluated. Then, the weighted gene coexpression network analysis (WGCNA) assisted in determining key modules, and we selected the genes exhibiting obvious association with necroptosis prognosis through the relationship with prognosis. The univariate Cox regression analysis together with least absolute shrinkage and selection operator (LASSO) techniques served for the construction of the necroptosis-related prognostic risk score (NPRS) model, and the pathway characteristics of NPRS model grouping were further studied. Finally, the NPRS, taking into account the clinicopathological features, used the decision tree model for enhancing the prognostic model as well as the survival prediction. First, two stable molecular subtypes with different prognosis and immune characteristics were identified using necroptosis marker genes. Then, the key modules were identified, and 10 genes significantly related to the prognosis of necroptosis were selected. Then, the clinical prognostic model of NPRS was developed considering the prognosis-linked necroptosis genes. Finally, the NPRS model, taking into account the clinicopathological features, adopted the decision tree model for enhancing the prognostic model as well as the survival prediction. Herein, two new molecular subgroups considering necroptosis-linked genes are proposed, and an NPRS model composed of 10 genes is developed, which maybe assist in the personalized treatment and clinical treatment guidance of TNBC patients.Keywords
Funding Information
- Shenzhen Special Fund for innovation and Entrepreneurship of overseas high-level talents (KQJSCX20180330124428928, LQ20H160038)
- Natural Science Foundation of Zhejiang Province (KQJSCX20180330124428928, LQ20H160038)
This publication has 34 references indexed in Scilit:
- Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expressionGenome Biology, 2016
- The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppressionNature, 2016
- Variable selection with stepwise and best subset approachesAnnals of Translational Medicine, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differencesOncotarget, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular targetProceedings of the National Academy of Sciences, 2006